T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
- Status
- TERMINATED
- Phase
- NA
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE3
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
Nivolumab Combined With BMS-986253 in HCC Patients
- Status
- TERMINATED
- Phase
- PHASE2
RFA Versus SBRT for Recurrent Small HCC
- Status
- COMPLETED
- Phase
- PHASE3
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
HAIC Plus Lenvatinib and Toripalimab for Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
- Status
- UNKNOWN
- Phase
- PHASE1
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Observational Study on Patients With Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- N/A
SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy
- Status
- COMPLETED
- Phase
- PHASE4